Dr. Koyfman on the Evolution of Reirradiation Treatment in Head and Neck Cancer

Video

In Partnership With:

Shlomo Koyfman, MD, associate staff, Radiation Oncology, Cleveland Clinic, discusses recent advancements in reirradiation treatment for patients with head and neck cancer.

Shlomo Koyfman, MD, associate staff, Radiation Oncology, Cleveland Clinic, discusses recent advancements in reirradiation treatment for patients with head and neck cancer.

The reirradiation setting in head and neck cancer has been fortunate enough to see better imaging in the last decade or so, including better PET scanning and MRI scanning. A radiation oncologist treats what he sees, Koyfman explains. Thus, as the ability to see more, and to see more clearly, has gotten so much more advanced, radiation oncologists are able to be more selective about how they treat patients.

Koyfman says he tells his patients that the head and neck is a very "high real estate" area of the body, meaning that a lot of important parts are all located very close to one another. Radiation oncologists are now been able to apply this improved understanding of those structures to the reirradiation setting. Moreover, with more advanced technology and planning, these physicians can be much more careful about how they deposit doses of radiation, and critical structures can now be spared from unnecessary toxicities.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute